| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
KZIA
Kazia Therapeutics
|
Jun 11, 2026 | BUY |
Strong Buy
+68.4% avg upside
6 analysts
|
$32.00
130.94% Upside
|
· |
|
OSTX
OS Therapies Incorporated
|
Jun 03, 2026 | BUY |
Strong Buy
+534.7% avg upside
4 analysts
|
$13.00
573.60% Upside
|
· |
|
IMNM
Immunome
|
Jun 01, 2026 | BUY |
Strong Buy
+83.2% avg upside
16 analysts
|
$30.00
60.08% Upside
|
-10.8% |
|
MNPR
Monopar Therapeutics Inc
|
Jun 01, 2026 | BUY |
Strong Buy
+46.7% avg upside
18 analysts
|
$103.00
52.67% Upside
|
· |
|
ONCY
Oncolytics Biotech
|
Jun 01, 2026 | BUY |
Strong Buy
+654.5% avg upside
12 analysts
|
$5.00
420.82% Upside
|
-19.8% |
|
COYA
Coya Therapeutics, Inc.
|
May 22, 2026 | BUY |
Strong Buy
+225.2% avg upside
7 analysts
|
$17.00
245.59% Upside
|
-2.9% |
|
CGEN
Compugen
|
May 19, 2026 | BUY |
Strong Buy
+170.9% avg upside
8 analysts
|
$6.00
198.54% Upside
|
· |
|
PSTV
Plus Therapeutics
|
May 19, 2026 | BUY |
Strong Buy
+688.7% avg upside
11 analysts
|
$50.00
1090.49% Upside
|
-7.0% |
|
LTRN
Lantern Pharma
|
May 18, 2026 | BUY |
Strong Buy
+491.8% avg upside
5 analysts
|
$25.00
559.66% Upside
|
· |
|
BOLT
Bolt Biotherapeutics
|
May 13, 2026 | BUY |
Buy
+475.8% avg upside
7 analysts
|
$75.00
1779.75% Upside
|
-5.6% |
|
GNLX
Genelux Corp.
|
May 08, 2026 | BUY |
Strong Buy
+513.8% avg upside
7 analysts
|
$16.00
439.54% Upside
|
-2.2% |
|
CLPT
ClearPoint Neuro
|
Apr 30, 2026 | BUY |
Strong Buy
+4.7% avg upside
7 analysts
|
— | +4.1% |
|
RNAC
Cartesian Therapeutics
|
Nov 01, 2021 | BUY |
Strong Buy
+228.5% avg upside
19 analysts
|
$7.00
27.39% Downside
|
-55.7% |
|
GB:0DPB
Bavarian Nordic AS
|
Sep 01, 2021 | BUY |
Strong Buy
+95.2% avg upside
5 analysts
|
$380.00
109.79% Upside
|
· |
|
GERN
Geron
|
Aug 17, 2021 | BUY |
Strong Buy
+240.0% avg upside
19 analysts
|
$3.00
138.09% Upside
|
+68.0% |
|
CRMD
Cormedix
|
Aug 13, 2021 | BUY |
Strong Buy
+73.5% avg upside
13 analysts
|
$29.00
234.41% Upside
|
-34.4% |
|
STTK
Shattuck Labs
|
Aug 12, 2021 | BUY |
Strong Buy
+369.1% avg upside
14 analysts
|
$49.00
889.80% Upside
|
-81.7% |
|
CELC
Celcuity
|
Aug 10, 2021 | BUY |
Strong Buy
+40.6% avg upside
16 analysts
|
$50.00
43.09% Downside
|
-49.0% |
|
ATHXQ
Athersys
|
Aug 10, 2021 | BUY |
Buy
+29964185.8% avg upside
8 analysts
|
$5.00
4999900.08% Upside
|
-82.3% |
|
CYTK
Cytokinetics
|
Aug 06, 2021 | BUY |
Strong Buy
+8.9% avg upside
36 analysts
|
$48.00
39.03% Downside
|
+62.8% |
|
NXTC
NextCure
|
Aug 06, 2021 | BUY |
Buy
+753.8% avg upside
10 analysts
|
$30.00
1385.25% Upside
|
-38.2% |
|
AUTL
Autolus Therapeutics
|
Aug 05, 2021 | BUY |
Strong Buy
+605.8% avg upside
16 analysts
|
$21.00
1290.76% Upside
|
-41.8% |
|
SYRE
Spyre Therapeutics
|
Aug 05, 2021 | BUY |
Strong Buy
-15.4% avg upside
23 analysts
|
$12.00
86.33% Downside
|
· |
|
AKBA
Akebia Therapeutics
|
Aug 05, 2021 | BUY |
Strong Buy
+831.9% avg upside
16 analysts
|
$10.00
834.64% Upside
|
-86.2% |
|
IONS
Ionis Pharmaceuticals
|
Aug 04, 2021 | BUY |
Strong Buy
+13.3% avg upside
43 analysts
|
$84.00
13.26% Upside
|
+14.5% |
|
VCEL
Vericel
|
Aug 04, 2021 | HOLD |
Strong Buy
+14.1% avg upside
16 analysts
|
— | -38.1% |
|
ESPR
Esperion
|
Aug 03, 2021 | BUY |
Buy
+701.2% avg upside
22 analysts
|
$114.00
3519.13% Upside
|
-59.6% |
|
GNCAQ
Genocea Biosciences
|
Jul 29, 2021 | BUY |
Strong Buy
+573999900.0% avg upside
10 analysts
|
$6.00
599999900.03% Upside
|
· |
|
NRIX
Nurix Therapeutics
|
Jul 15, 2021 | BUY |
Strong Buy
+76.3% avg upside
26 analysts
|
$48.00
173.43% Upside
|
-30.0% |
|
EXEL
Exelixis
|
Jun 28, 2021 | BUY |
Strong Buy
-21.1% avg upside
33 analysts
|
$30.00
42.22% Downside
|
+16.2% |
|
NBP
NovaBridge Biosciences
|
Jun 07, 2021 | BUY |
Strong Buy
+1306.0% avg upside
14 analysts
|
$83.00
5433.25% Upside
|
· |
|
SRPT
Sarepta Therapeutics
|
May 18, 2021 | BUY |
Buy
+246.5% avg upside
49 analysts
|
$166.00
847.00% Upside
|
-15.9% |
|
MREO
Mereo Biopharma Group Plc
|
May 14, 2021 | BUY |
Strong Buy
+1146.9% avg upside
11 analysts
|
$10.00
3131.98% Upside
|
-87.4% |
|
AGIO
Agios Pharma
|
May 10, 2021 | HOLD |
Strong Buy
+73.8% avg upside
29 analysts
|
— | -60.9% |
|
WHWK
Whitehawk Therapeutics
|
Nov 08, 2019 | HOLD |
Buy
+201.4% avg upside
12 analysts
|
— | +140.7% |
|
SMMT
Summit Therapeutics
|
Apr 12, 2018 | BUY |
Strong Buy
+112.6% avg upside
27 analysts
|
$27.00
96.42% Upside
|
-86.2% |
|
ACHV
Achieve Life Sciences
|
Dec 09, 2016 | BUY |
Strong Buy
+208.7% avg upside
12 analysts
|
$33.00
580.49% Upside
|
· |
|
TLOG
Tetralogic Pharma
|
May 07, 2015 | BUY |
Strong Buy
+10833233.4% avg upside
3 analysts
|
$7.00
17499900.01% Upside
|
· |
|
SLS
SELLAS Life Sciences Group
|
Mar 06, 2015 | BUY |
Strong Buy
+768.3% avg upside
15 analysts
|
$4.00
50.26% Downside
|
-47.9% |
|
OCGN
Ocugen
|
Jan 05, 2015 | BUY |
Strong Buy
+646.0% avg upside
17 analysts
|
$17.00
1270.94% Upside
|
-72.8% |
|
PLUR
Pluri
|
May 22, 2012 | BUY |
Strong Buy
+197.0% avg upside
8 analysts
|
$5.00
147.55% Upside
|
+14.1% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.